Fang Hong H - OmicsDI

Show results for

Unknown (776)
Proteomics (32)
Transcriptomics (13)
Metabolomics (5)
Genomics (1)

Organisms

Homo sapiens (19)
Schizophyllum commune H4-8 (7)
Mycobacterium tuberculosis SP7 (7)
Salmonella enterica subsp. enterica serovar Typhimurium str. T000240 (7)
Oryza sativa Japonica Group (7)
Rabbit calicivirus (7)
Crotalus durissus terrificus (7)
Eriocheir sinensis (7)
Candidatus Endoriftia persephonae (7)
Mycobacterium tuberculosis SP10 (7)
Mycobacterium tuberculosis SP13 (7)
Cotesia typhae (7)
Mycobacterium tuberculosis SP22 (7)
Cepaea nemoralis (7)
Enterobacter ludwigii (7)
Trichoderma asperellum CBS 433.97 (7)
Corynebacterium diphtheriae bv. mitis str. ISS 3319 (7)
Nakaseomyces glabratus (7)
Olea europaea (7)
Chlamydomonas reinhardtii (7)
Mus musculus (5)
Escherichia coli (5)
Rattus norvegicus (3)
Mycobacterium tuberculosis H37Rv_2009 (2)
Gossypium hirsutum (1)
Mycobacterium tuberculosis (1)
Fragaria vesca subsp. vesca (1)
Dimocarpus longan (1)
Severe acute respiratory syndrome coronavirus 2 (1)
Chlorocebus sabaeus (1)

Repository

iProX (25)
biostudies-arrayexpress (13)
pride (7)
MetaboLights (5)
EGA (1)

Tissue

Kidney (3)
Nectar (1)
Secretion (1)

Disease

Nephrotic syndrome (1)
IgA glomerulonephritis (1)

Technology Type

Mass Spectrometry (7)
Mass spectrometry (3)
Gel-based experiment (2)
Chemical cross-linking coupled with mass spectrometry proteomics (2)
NMR spectroscopy (1)
Mass spectrometry assay (1)
Data-independent acquisition (1)
Top-down proteomics (1)
Bottom-up proteomics (1)
Affinity purification coupled with mass spectrometry proteomics (1)
Shotgun proteomics (1)

Instrument Platform

Illumina HiSeq 4000 (2)
Gas Chromatography MS - Positive (GC-MS (Positive)) (1)
LTQ Orbitrap Velos (Thermo Scientific) (1)
API 5500 QTRAP (AB Sciex) (1)
Bruker (1)
Liquid Chromatography MS - (1)
Liquid Chromatography MS - positive - reverse phase (1)
Liquid Chromatography MS - negative - reverse phase (1)

Publication Date

2022 (9)
2021 (8)
2026 (6)
2014 (4)
2020 (4)
2018 (2)
2015 (2)
2013 (2)
2009 (2)
2019 (1)
2012 (1)
2006 (1)
2024 (1)
2023 (1)
2017 (1)
2025 (1)

CHEBI ID

CHEBI:16865 (3)
CHEBI:30769 (3)
CHEBI:17822 (2)
CHEBI:26271 (2)
CHEBI:22660 (2)
CHEBI:22653 (2)
CHEBI:24898 (2)
CHEBI:25017 (2)
CHEBI:28842 (2)
CHEBI:15428 (2)
CHEBI:6650 (2)
CHEBI:28044 (2)
CHEBI:16335 (2)
CHEBI:17568 (2)
CHEBI:27266 (2)
CHEBI:15891 (2)
CHEBI:16449 (2)
CHEBI:16704 (2)
CHEBI:16919 (2)
CHEBI:16347 (2)
CHEBI:15354 (2)
CHEBI:193499 (1)
CHEBI:193498 (1)
CHEBI:193497 (1)
CHEBI:193496 (1)
CHEBI:193508 (1)
CHEBI:193495 (1)
CHEBI:189758 (1)
CHEBI:193494 (1)
CHEBI:193493 (1)

Metabolite Name

Citric acid (3)
Guanosine (2)
3-(4-methoxyphenyl)-1-(2,3,4,6-tetrahydroxyphenyl)propan-1-one (1)
Aflatoxin Q2a (1)
Dumosol (1)
Thonningine A (1)
Quercetagetin 3-methyl ether 7-O-sulfate (1)
[5,6,7-trihydroxy-2-(3-hydroxyphenyl)-4-oxo-3,4-dihydro-2H-1-benzopyran-3-yl]oxidanesulfonic acid (1)
Epicatechin 5,7,3'-trimethyl ether (1)
3-(3,4-dimethoxyphenyl)-3,4-dihydro-2H-1-benzopyran-7-ol (1)
5,6,7-trihydroxy-2-(3-hydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-4-one (1)
{2-hydroxy-5-[2-hydroxy-3-(2,4,6-trihydroxyphenyl)propyl]phenyl}oxidanesulfonic acid (1)
20(17->12beta)-abeo-1alpha,25-dihydroxy-24-dihomo-21-norvitamin D3 (1)
3,4,5-trihydroxy-6-[(2,3,5-trihydroxy-6-methyloxan-4-yl)oxy]oxane-2-carboxylic acid (1)
[4-(3,5,7-trihydroxy-3,4-dihydro-2H-1-benzopyran-2-yl)phenyl]oxidanesulfonic acid (1)
2-Nor-1,3-seco-1alpha,25-dihydroxyvitamin D3 (1)
Alpha-CMBHC (1)
5,7,8-trihydroxy-2-(4-methoxyphenyl)-3,4-dihydro-2H-1-benzopyran-4-one (1)
2'-Hydroxy-7-methoxy-4',5'-methylenedioxyflavan (1)
{4,8-dihydroxy-17-methoxy-10-oxo-2-oxatricyclo[13.2.2.1?,?]icosa-1(17),3,5,7(20),15,18-hexaen-14-yl}oxidanesulfonic acid (1)
2-[2,4-dihydroxy-3-(3-methylbut-2-en-1-yl)phenyl]-2-hydroxyacetic acid (1)
6-({3-[(1E)-but-1-en-1-yl]-6-hydroxy-1-oxo-1H-isochromen-5-yl}oxy)-3,4,5-trihydroxyoxane-2-carboxylic acid (1)
7,8,4'-Trihydroxy-3-methoxyflavone (1)
{4-[3-(3,5-dihydroxyphenyl)oxiran-2-yl]phenyl}oxidanesulfonic acid (1)
2,5-Dihydroxy-7-methoxy-8-methylflavanone (1)
Isochenodeoxycholic acid (1)
(E)-octadeca-15,17-dien-9,11,13-triynoic acid (1)
3alpha,12alpha,22-Trihydroxy-5beta-cholestan-26-oic acid (1)
5,6,7-Trihydroxyflavone 7-(6''-malonylglucoside) (1)
5,7,3',5'-Tetrahydroxy-6-methylflavanone (1)

Study type

Transcription profiling by array (10)
RNA-seq of coding RNA (3)

Release Date

2025 (141)
2022 (100)
2024 (97)
2023 (85)
2021 (80)
2020 (64)
2019 (44)
2018 (34)
2014 (27)
2017 (24)
2016 (23)
2026 (16)
2015 (15)
2013 (12)
2012 (8)
2010 (8)
2005 (3)
2009 (2)
2006 (2)
2011 (2)
2008 (2)

Lab affiliation

Nanjing University (2)
Department of Nephrology, Children's Hospital of Fudan University, National Pediatric Medical Center of China, Shanghai, China. (1)
Department of Nephrology, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China;Guangdong-Hong Kong Joint Laboratory on Immunological and Genetic Kidney Diseases; Guangzhou, China. (1)
State Key Laboratory of Pharmaceutical Biotechnology, Jiangsu Key Laboratory of Molecular Medicine, Medical School of Nanjing University, Nanjing, China. (1)
The State Key Laboratory of Pharmaceutical Biotechnology, Medical School, School of Life Sciences, Nanjing University, Nanjing, China (1)
Huangshan University (1)

Previous page
1 / 83
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 83
Next page

Sort by:

Relevance

Page size

Serum proteomic, peptidomic and metabolomic profiles in myasthenia gravis patients during treatment with Qiangji Jianli Fang.

Not available

S-EPMC3464942 | biostudies-literature

Estimating excess septicaemia mortality and hospitalisation burden associated with influenza in Hong Kong, 1998 to 2019.

Not available

S-EPMC9128349 | biostudies-literature

Bushen Yijing Fang Reduces Fall Risk in Late Postmenopausal Women with Osteopenia: A Randomized Double-blind and Placebo-controlled Trial.

Not available

S-EPMC6375933 | biostudies-literature

Exploring the mechanism of Suxin Hugan Fang in treating ulcerative colitis based on network pharmacology.

Not available

S-EPMC11549446 | biostudies-literature

Standards for reporting interventions in clinical trials of cupping (STRICTOC): extending the CONSORT statement.

Not available

S-EPMC6995163 | biostudies-literature

A network meta-analysis on the effectiveness and safety of acupuncture in treating patients with major depressive disorder.

Not available

S-EPMC8129113 | biostudies-literature

Spatial and functional dissection of cancer-associated fibroblasts-mediated immune modulation in H. pylori-associated gastric cancer.

Not available

S-EPMC12590883 | biostudies-literature

Discovery of the genes controlled by the second messenger cyclic di-GMP in Mycobacterium tuberculosis

Cyclic di-GMP (c-di-GMP) is a ubiquitous second messenger that regulates many biological processes in bacteria. The genome in Mycobacterium tuberculosis encodes a single copy of the diguanylate cyclase gene (dgc) responsible for c-di-GMP synthesis. To determine the role of c-di-GMP signaling in M. t...

ORGANISM(S): Mycobacterium tuberculosis

2013-10-09 | E-GEOD-37973 | biostudies-arrayexpress

A Machine Learning Model for Predicting the Propagation Rate Coefficient in Free-Radical Polymerization.

Not available

S-EPMC11477705 | biostudies-literature

Conformally Mapped Multifunctional Acoustic Metamaterial Lens for Spectral Sound Guiding and Talbot Effect.

Not available

S-EPMC6944515 | biostudies-literature